MSS01 STEM CELL-SEEDED BIOPROSTHETIC MESH DEMONSTRATES IMPROVED RESISTANCE TO INFECTION AND IMPROVED TISSUE INCORPORATION IN A RAT MODEL
Erik T Criman, MD1, Wendy E Kurata, MS2, Karen W Matsumoto, BS2, Harry T Aubin, MD1, Carmen E Campbell, MS2; 1Tripler Army Medical Center, 2Department of Clinical Investigation, TAMC
MSS02 BEYOND REBOA: AN EXPERIMENTAL MODEL OF ENDOVASCULAR VARIABLE AORTIC CONTROL (EVAC)
Rachel Russo, MD1, Sarah-Ashley Ferencz, MD1, Anders Davidson, MD1, Joseph Galante, MD2, James Sampson1, Joseph Dubose1, John K Grayson, DVM, PHD1, Lucas Neff, MD1, Timothy Williams, MD1; 1Clinical Investigations Facility, David Grant Medical Center, Travis, AFB, 2University of California Davis Medical Center
MSS03 THERE’S AN APP FOR THAT: A HANDHELD SMARTPHONE-BASED INFRARED IMAGING DEVICE TO ASSESS ADEQUACY AND LEVEL OF AORTIC OCCLUSION
Kyle K Sokol, MD, George E Black, MD, Matthew J Eckert, MD, Matthew J Martin, MD, FACS; Madigan Army Medical Center
MSS04 ANALYSIS OF CLINICOPATHOLOGIC FACTORS AMONGST CONTROL PATIENTS IN THE PHASE II TRIAL OF AE37 OR GP2+GMCSF VS GM-CSF ALONE IN HIGH RISK BREAST CANCER PATIENTS – IMPLICATIONS FOR FUTURE TRIAL DESIGN
Alfred F Trappey, MD1, John S Berry, MD1, Julia M Greene, MD1, Doreen 0 Jackson, MD1, Diane F Hale, MD1, Timothy J Vreeland, MD1, Guy T Clifton, MD1, Garth S Herbert, MD1, Sonja Perez, PhD2, M Papamichail, MD, PhD2, Elizabeth A Mittendorf, MD, PhD3, George E Peoples, MD4; 4Cancer Vaccine Development Program, 1Brooke Army Medical Center, 2Cancer Immunology and Immunotherapy Center (Greece), 3MD Ancerson Cancer Center
MSS05 LOCALLY APPLIED ENZYME ACTIVATED TACROLIMUS ELUTING HYDROGELS SIGNIFICANTLY DELAY THE ONSET OF ACUTE REJECTION IN VASCULARIZED COMPOSITE ALLOGRAFTS
R Cindass1, S D Lawson2, C A Fries3, K Wu2, L C Wang1, J M Karp4, P K Vemula5, N Desai4, R F Rickard3, V S Gorantla6, M R Davis7; 1RESTOR, 59th Medical Wing, and San Antonio Military Medical Center, 2RESTOR, 59th Medical Wing, and University of Texas Health Science Center at San Antonio, 3The Royal Centre for Defence Medicine, 4Brigham and Women’s Hospital, 5Institute for Stem Cell Biology and Regenerative Medicine, 6University of Pittsburgh Medical Center, 7RESTOR and 59th Medical Wing
MSS06 HYDROGEN SULFIDE DELAYS ONSET OF ACUTE REJECTION IN PORCINE VCA MODEL
Kevin Y Wu1, C A Fries2, J R Spencer3, Mark Roth3, V S Gorantla4, M R Davis1; 1RESTOR 59th Medical Wing, 2Royal Centre for Defence Medicine, 359th Medical Wing, 4University of Pittsburgh Medical Center
MSS07 HYPERBARIC SUB-NORMOTHERMIC EX-VIVO PERFUSION DELAYS THE ONSET OF ACUTE REJECTION IN A PORCINE VCA MODEL
Fries A Charles1, Sharon Lawson, MD2, Lin C Wang, MD3, Vijay Gorantla, MD4, Carole Villamaria, MD2, Michael Davis, MD5; 1Royal Centre for Defence Medicine, 2RESTOR 59th Medical Wing and University of Texas Health Science Center at San Antonio, 3RESTOR 59th Medical Wing and San Antonio Military Medical Center, 4University of Pittsburgh Medical Center, 5RESTOR 59th Medical Wing
MSS08 DIFFERENTIAL EXPRESSION OF PLASMA EXOSOME RNAS AS POTENTIAL NONINVASIVE BIOMARKERS OF GULF WAR ILLNESS: EVALUATION IN A RAT MODEL
Bonnie B Tulk, DO1, Wendy Kurata, MS2, Karen Matsumoto, BS2, Douglas Farmer, MD1, Margaret Clark, MD1, Lisa Pierce, DSc2; 1Department of General Surgery, Tripler Army Medical Center, 2Department of Clinical Investigation, Tripler Army Medical Center